The Uromigos
The Uromigos
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing
16 minutes
Posted Jun 7, 2021 at 3:24 pm.
0:00
16:48
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Matt Galsky describes his Phase 2 study and gives a vision of the future.
Previous
Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021
Next
Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer
← See all 501 episodes of The Uromigos